{ "cik": 872589, "cik_padded": "0000872589", "entityName": "REGENERON PHARMACEUTICALS, INC.", "fiscal_years": [ { "accn": "0000872589-26-000008", "filed": "2026-02-04", "fiscal_year": 2025, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 3438600000.0, "capex": 898400000.0, "cash": 3118100000.0, "dividends_paid": 370300000.0, "eps_diluted": 41.48, "free_cash_flow": 4080500000.0, "net_income": 4504900000.0, "operating_cash_flow": 4978900000.0, "operating_income": 3577900000.0, "revenue": 14342900000.0, "stockholders_equity": 31256900000.0, "total_assets": 40558700000.0, "total_liabilities": 9301800000.0 }, "period_end": "2025-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.29759189171031036, "net_margin": 0.31408571488332204, "operating_margin": 0.24945443390109392, "payout_ratio": 0.0821993828941819, "revenue_growth_yoy": 0.00992113786790593, "roa_avg2y": 0.11504109522575241, "roa_period_end": 0.11107111421224053, "roe_avg2y": 0.14865081132807023, "roe_period_end": 0.14412497720503312 } }, { "accn": "0000872589-26-000008", "filed": "2026-02-04", "fiscal_year": 2024, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2603300000.0, "capex": 755900000.0, "cash": 2488200000.0, "dividends_paid": 0.0, "eps_diluted": 38.34, "free_cash_flow": 3664600000.0, "net_income": 4412600000.0, "operating_cash_flow": 4420500000.0, "operating_income": 3990700000.0, "revenue": 14202000000.0, "stockholders_equity": 29353600000.0, "total_assets": 37759400000.0, "total_liabilities": 8405800000.0 }, "period_end": "2024-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.286363512482285, "net_margin": 0.3107027179270525, "operating_margin": 0.28099563441768766, "payout_ratio": 0.0, "revenue_growth_yoy": 0.08270057634251213, "roa_avg2y": 0.12458003715435999, "roa_period_end": 0.11686096707045132, "roe_avg2y": 0.15951068832950457, "roe_period_end": 0.1503256840728224 } }, { "accn": "0001804220-25-000011", "filed": "2026-02-04", "fiscal_year": 2023, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "dividends_paid": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2235000000.0, "capex": 718600000.0, "cash": 2730000000.0, "dividends_paid": 0.0, "eps_diluted": 34.77, "free_cash_flow": 3875400000.0, "net_income": 3953600000.0, "operating_cash_flow": 4594000000.0, "operating_income": 4047100000.0, "revenue": 13117200000.0, "stockholders_equity": 25973100000.0, "total_assets": 33080200000.0, "total_liabilities": 7107100000.0 }, "period_end": "2023-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "payout_ratio": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.27363310502019395, "net_margin": 0.3014057878205715, "operating_margin": 0.3085338334400634, "payout_ratio": 0.0, "revenue_growth_yoy": 0.0775739552612771, "roa_avg2y": 0.12693214671553119, "roa_period_end": 0.11951560147762105, "roe_avg2y": 0.16257548250204062, "roe_period_end": 0.15221902660829859 } }, { "accn": "0001804220-25-000011", "filed": "2026-02-04", "fiscal_year": 2022, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 2082800000.0, "capex": 590100000.0, "cash": 3105900000.0, "eps_diluted": 38.22, "free_cash_flow": 4424800000.0, "net_income": 4338400000.0, "operating_cash_flow": 5014900000.0, "operating_income": 4738900000.0, "revenue": 12172900000.0, "stockholders_equity": 22664000000.0, "total_assets": 29214500000.0, "total_liabilities": 6550500000.0 }, "period_end": "2022-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.2890266501941405, "net_margin": 0.35639822885261524, "operating_margin": 0.3892991809675591, "revenue_growth_yoy": -0.24258790295986113, "roa_avg2y": 0.15877239049722502, "roa_period_end": 0.14850160023276113, "roe_avg2y": 0.20941862485760074, "roe_period_end": 0.19142252029650547 } }, { "accn": "0001804220-25-000011", "filed": "2025-02-05", "fiscal_year": 2021, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 1645400000.0, "capex": 551900000.0, "cash": 2885600000.0, "eps_diluted": 71.97, "free_cash_flow": 6529400000.0, "net_income": 8075300000.0, "operating_cash_flow": 7081300000.0, "operating_income": 8946800000.0, "revenue": 16071700000.0, "stockholders_equity": 18768800000.0, "total_assets": 25434800000.0, "total_liabilities": 6666000000.0 }, "period_end": "2021-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3551638890072887, "net_margin": 0.5024546252107742, "operating_margin": 0.5566803760647598, "revenue_growth_yoy": 0.8914335479163479, "roa_avg2y": 0.379138975682014, "roa_period_end": 0.3174902102631041, "roe_avg2y": 0.5420737662825862, "roe_period_end": 0.43025126806188996 } }, { "accn": "0001804220-24-000009", "filed": "2024-02-05", "fiscal_year": 2020, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 5846800000.0, "capex": 614600000.0, "cash": 2193700000.0, "eps_diluted": 30.52, "free_cash_flow": 2003500000.0, "net_income": 3513200000.0, "operating_cash_flow": 2618100000.0, "operating_income": 3576600000.0, "revenue": 8497100000.0, "stockholders_equity": 11025300000.0, "total_assets": 17163300000.0, "total_liabilities": 6138000000.0 }, "period_end": "2020-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5567195450463933, "net_margin": 0.41345870944204494, "operating_margin": 0.4209200786150569, "revenue_growth_yoy": 0.29576369403440284, "roa_avg2y": 0.21979135711716222, "roa_period_end": 0.20469257077601624, "roe_avg2y": 0.3177210038435451, "roe_period_end": 0.3186489256528167 } }, { "accn": "0001804220-23-000008", "filed": "2023-02-06", "fiscal_year": 2019, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 275900000.0, "capex": 429600000.0, "cash": 1617800000.0, "eps_diluted": 18.46, "free_cash_flow": 2000400000.0, "net_income": 2115800000.0, "operating_cash_flow": 2430000000.0, "operating_income": 2209800000.0, "revenue": 6557600000.0, "stockholders_equity": 11089700000.0, "total_assets": 14805200000.0, "total_liabilities": 3715500000.0 }, "period_end": "2019-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3350406232810626, "net_margin": 0.3226485299499817, "operating_margin": 0.33698304257655237, "revenue_growth_yoy": 0.2744092039800995, "roa_avg2y": 0.15944415347573634, "roa_period_end": 0.14290924810201822, "roe_avg2y": 0.21321106464453066, "roe_period_end": 0.1907896516587464 } }, { "accn": "0001804220-22-000007", "filed": "2022-02-07", "fiscal_year": 2018, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 4400000.0, "capex": 383100000.0, "cash": 1467700000.0, "eps_diluted": 21.29, "free_cash_flow": 1812000000.0, "net_income": 2444400000.0, "operating_cash_flow": 2195100000.0, "operating_income": 2534400000.0, "revenue": 5145600000.0, "stockholders_equity": 8757300000.0, "total_assets": 11734500000.0, "total_liabilities": 2977200000.0 }, "period_end": "2018-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.3399677982939947, "net_margin": 0.47504664179104483, "operating_margin": 0.49253731343283585, "revenue_growth_yoy": -0.12373556758965976, "roa_avg2y": 0.2384920092883486, "roa_period_end": 0.20830883292854405, "roe_avg2y": 0.32807655656515494, "roe_period_end": 0.27912712822445274 } }, { "accn": "0001804220-21-000008", "filed": "2021-02-08", "fiscal_year": 2017, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 272600000.0, "cash": 812700000.0, "eps_diluted": 10.34, "free_cash_flow": 1034500000.0, "net_income": 1198500000.0, "operating_cash_flow": 1307100000.0, "operating_income": 2079600000.0, "revenue": 5872200000.0, "stockholders_equity": 6144100000.0, "total_assets": 8764300000.0, "total_liabilities": 2620200000.0 }, "period_end": "2017-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "revenue_growth_yoy": "ratio", "roa_avg2y": "ratio", "roa_period_end": "ratio", "roe_avg2y": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.4264579027034065, "net_margin": 0.20409727189128435, "operating_margin": 0.35414325125166035, "revenue_growth_yoy": 0.20817216689984364, "roa_avg2y": 0.15230878385153268, "roa_period_end": 0.13674794336113552, "roe_avg2y": 0.22627296241055753, "roe_period_end": 0.1950651844859296 } }, { "accn": "0001532176-20-000008", "filed": "2020-02-07", "fiscal_year": 2016, "form": "10-K", "fundamental_units": { "buybacks": "USD", "capex": "USD", "cash": "USD", "eps_diluted": "USD/shares", "free_cash_flow": "USD", "net_income": "USD", "operating_cash_flow": "USD", "operating_income": "USD", "revenue": "USD", "stockholders_equity": "USD", "total_assets": "USD", "total_liabilities": "USD" }, "fundamentals": { "buybacks": 0.0, "capex": 511900000.0, "cash": 535200000.0, "eps_diluted": 7.7, "free_cash_flow": 974000000.0, "net_income": 895500000.0, "operating_cash_flow": 1485900000.0, "operating_income": 1330700000.0, "revenue": 4860400000.0, "stockholders_equity": 4449300000.0, "total_assets": 6973466000.0, "total_liabilities": 2524221000.0 }, "period_end": "2016-12-31", "ratio_units": { "leverage": "ratio", "net_margin": "ratio", "operating_margin": "ratio", "roa_period_end": "ratio", "roe_period_end": "ratio" }, "ratios": { "leverage": 0.5673299170656059, "net_margin": 0.18424409513620277, "operating_margin": 0.273784050695416, "roa_period_end": 0.12841533894336044, "roe_period_end": 0.20126761513046992 } } ], "latest_filing": { "accn": "0000872589-26-000008", "filed": "2026-02-04", "form": "10-K" }, "note": "Static grepcent export of verified SEC companyfacts-derived values. Monetary values are raw reported units from grepcent's resolved facts; no scaling and no FX conversion. Capex, dividends, and buybacks are reported as positive outflow magnitudes. ROE/ROA include both period-end basis (site-consistent) and average-of-two-years basis where the prior-year denominator exists.", "schema_version": "1", "sic": "2834", "sic_description": "Pharmaceutical Preparations", "source_urls": { "sec_companyfacts": "https://data.sec.gov/api/xbrl/companyfacts/CIK0000872589.json", "sec_submissions": "https://data.sec.gov/submissions/CIK0000872589.json" }, "ticker": "REGN" }